文献速递急性肾损伤慢性肾脏病肾血管病与高血压

羊毛甾醇合酶基因变异、内源性哇巴因与急慢性肾损伤

Lanosterol Synthase Genetic Variants, Endogenous Ouabain, and Both Acute and Chronic Kidney Injury.
PubMed 文献 · Am J Kidney Dis · 2019-01-16

该研究通过两项前瞻性队列和一项肾组织横断面研究,探讨LSS rs2254524变异、内源性哇巴因(EO)与急性肾损伤(AKI)及慢性肾损伤的关系。结果发现AA基因型者心脏术后AKI发生率更高、肾组织EO浓度更高,且高血压患者eGFR下降更快。提示该变异可用于风险分层,EO或为治疗靶点。

要点

  • LSS rs2254524 AA基因型与心脏术后AKI风险升高相关。
  • AA基因型肾组织EO浓度显著高于CC基因型。
  • AA基因型高血压患者eGFR下降速度更快。

核心结论

  • LSS rs2254524基因型可用于心脏术前AKI风险分层,并预测高血压患者eGFR加速下降。
  • LSS可能部分驱动EO介导的肾损伤,EO或为预防AKI和延缓高血压肾损伤的新靶点。

研究设计与样本

  • 两项前瞻性观察性队列研究(心血管手术患者、新诊断原发性高血压患者)和一项肾组织横断面研究。
  • 暴露为LSS rs2254524错义变异(C→A,导致第642位氨基酸缬氨酸→亮氨酸)。

主要发现

  • 心脏术后AKI发生率在AA基因型为30.7%,CC基因型为17.4%(P=0.001)。
  • AA基因型肾组织EO浓度为2.14±0.29 ng/g,高于CC基因型的1.25±0.08 ng/g(P<0.001)。
  • 高血压患者中位随访4年(范围1-15年),AA基因型eGFR下降为-4.39±1.18 mL/min/1.73m²/年,AC和CC基因型分别为-1.07±0.55和-2.00±0.45 mL/min/1.73m²/年(P=0.03)。

临床怎么用

  • 对接受心血管手术的患者可考虑检测LSS rs2254524基因型以识别AKI高危人群。
  • 高血压患者若携带AA基因型,可能需更密切监测eGFR变化。

局限性

  • 这些关联不一定代表因果关系。
  • LSS rs2254524变异可能影响其他类固醇激素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Studies of humans and animals have suggested that endogenous ouabain (EO) and related genes are mediators of acute (AKI) and chronic kidney injury. We sought to examine the relationship among EO levels, genetic variants in lanosterol synthase (LSS; an enzyme that catalyzes synthesis of cholesterol, a precursor of EO), and both AKI and chronic kidney injury. STUDY DESIGN: 2 prospective observational cohort studies and a cross-sectional study of kidney tissue. SETTING & PARTICIPANTS: (1) A prospective cohort study of patients undergoing cardiovascular surgery, (2) measurement of EO concentration in kidney tissue removed because of an adjacent tumor, and (3) a prospective cohort study of patients with newly diagnosed essential hypertension. EXPOSURE: Missense variant in LSS (A instead of C allele at rs2254524), which leads to a valine to leucine substitution at amino acid 642. OUTCOMES: Development of postoperative AKI in the cardiovascular surgery cohort, EO concentration in kidney tissue, and estimated glomerular filtration rate (eGFR) reductions in the essential hypertension cohort. ANALYTICAL APPROACH: Logistic regression for analysis of postoperative AKI, analysis of variance for EO concentration in kidney tissue, and generalized linear models for changes in eGFR over time. RESULTS: AKI incidence following cardiovascular surgery was greater among those with the LSS rs2254524 AA genotype (30.7%) than in those with the CC genotype (17.4%; P=0.001). LSS rs2254524 AA kidneys had higher EO concentrations than CC kidneys (2.14±0.29 vs 1.25±0.08ng/g; P<0.001). In the longitudinal study of patients with essential hypertension (median follow-up, 4 years; range, 1-15 years), eGFR decline was greater among the LSS rs2254524 AA genotype group (-4.39±1.18mL/min/1.73m2 per year) than in the AC or CC genotype groups (-1.07±0.55 and -2.00±0.45mL/min/1.73m2 per year respectively; P = 0.03). LIMITATIONS: These associations do not necessarily represent causal relationships; LSS rs2254524 variants may have effects on other steroid hormones. CONCLUSIONS: These findings support the potential value of LSS rs2254524 genotype-based risk stratification to identify patients at high risk for AKI before cardiovascular surgery, as well as predict accelerated eGFR in the setting of hypertension. These findings also suggest that LSS may in part drive EO-mediated kidney damage. EO may represent a new potential therapeutic target for the prevention of AKI and slowing of kidney damage in the setting of hypertension.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Iatrino R, Lanzani C, Bignami E, et al. Lanosterol Synthase Genetic Variants, Endogenous Ouabain, and Both Acute and Chronic Kidney Injury. Am J Kidney Dis. 2019. PMID: 30660405. doi:10.1053/j.ajkd.2018.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。